Patents by Inventor Alexandra Trotier-Faurion

Alexandra Trotier-Faurion has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CREATINE PRODRUGS, COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20240092731
    Abstract: The present disclosure provides creatine prodrug analogs and their compositions useful for the treatment of creatine deficiencies.
    Type: Application
    Filed: July 14, 2023
    Publication date: March 21, 2024
    Inventors: Yiumo CHAN, Emil D. KAKKIS, Alexandra TROTIER-FAURION, William F. BRUBAKER, Arjun NATESAN, Paul LEE, Sharyl FYFFE-MARICICH, David LAPOINTE, Mike E. LIZARZABURU
  • Creatine prodrugs, compositions and methods of use thereof
    Patent number: 11753369
    Abstract: The present disclosure provides creatine prodrug analogs and their compositions useful for the treatment of creatine deficiencies.
    Type: Grant
    Filed: March 28, 2022
    Date of Patent: September 12, 2023
    Assignee: Ultragenyx Pharmaceutical Inc.
    Inventors: Yiumo Chan, Emil D. Kakkis, Alexandra Trotier-Faurion, William F. Brubaker, Arjun Natesan, Paul Lee, Sharyl Fyffe-Maricich, David Lapointe, Mike E. Lizarzaburu
  • CREATINE PRODRUGS, COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20220227703
    Abstract: The present disclosure provides creatine prodrug analogs and their compositions useful for the treatment of creatine deficiencies.
    Type: Application
    Filed: March 28, 2022
    Publication date: July 21, 2022
    Inventors: Yiumo CHAN, Emil D. KAKKIS, Alexandra TROTIER-FAURION, William F. BRUBAKER, Arjun NATESAN, Paul LEE, Sharyl FYFFE-MARICICH, David LAPOINTE, Mike E. LIZARZABURU
  • Creatine prodrugs, compositions and methods of use thereof
    Patent number: 11332438
    Abstract: The present disclosure provides creatine prodrug analogs and their compositions useful for the treatment of creatine deficiencies.
    Type: Grant
    Filed: December 3, 2018
    Date of Patent: May 17, 2022
    Assignee: Ultragenyx Pharmaceutical Inc.
    Inventors: Yiumo Chan, Emil D. Kakkis, Alexandra Trotier-Faurion, William F. Brubaker, Arjun Natesan, Paul Lee, Sharyl Fyffe-Maricich, David Lapointe, Mike E. Lizarzaburu
  • CREATINE PRODRUGS, COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20210002211
    Abstract: The present disclosure provides creatine prodrug analogs and their compositions useful for the treatment of creatine deficiencies.
    Type: Application
    Filed: December 3, 2018
    Publication date: January 7, 2021
    Inventors: Yiumo CHAN, Emil D. KAKKIS, Alexandra TROTIER-FAURION, William F. BRUBAKER, Arjun NATESAN, Paul LEE, Sharyl FYFFE-MARICICH, David LAPOINTE, Mike E. LIZARZABURU
  • Method for preparing creatine fatty esters, creatine fatty esters thus prepared and uses thereof
    Patent number: 10144705
    Abstract: The present invention concerns a method for preparing a creatine fatty ester or derivative thereof comprising at least one step consisting in reacting a diprotected creatinine with a molecule bearing at least one alcohol functional group and of formula R?—OH in which R? represents a hydrocarbon radical containing at least 4 carbon atoms. The present invention also concerns particular creatine fatty esters or derivative thereof and medical uses thereof.
    Type: Grant
    Filed: July 17, 2013
    Date of Patent: December 4, 2018
    Assignee: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
    Inventors: Sophie Dezard, Frederic Taran, Alexandra Trotier-Faurion, Aloise Mabondzo
  • METHOD FOR PREPARING CREATINE FATTY ESTERS, CREATINE FATTY ESTERS THUS PREPARED AND USES THEREOF
    Publication number: 20150299112
    Abstract: The present invention concerns a method for preparing a creatine fatty ester or derivative thereof comprising at least one step consisting in reacting a diprotected creatinine with a molecule bearing at least one alcohol functional group and of formula R?—OH in which R? represents a hydrocarbon radical containing at least 4 carbon atoms. The present invention also concerns particular creatine fatty esters or derivative thereof and medical uses thereof.
    Type: Application
    Filed: July 17, 2013
    Publication date: October 22, 2015
    Applicant: Commissariat a l'energie atomique et aux energies alternatives
    Inventors: Sophie Dezard, Frederic Taran, Alexandra Trotier-Faurion, Aloise Mabondzo